Order Article Reprints

Chen Y-A, Tzeng DTW, Huang Y-P, Lin C-J, Lo U-G, Wu C-L, Lin H, Hsieh J-T, Tang C-H, Lai C-H. Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways. Cancers. 2019; 11(1):34. https://doi.org/10.3390/cancers11010034

Chen, Yu-An, David T. W. Tzeng, Yi-Ping Huang, Chun-Jung Lin, U-Ging Lo, Chia-Lin Wu, Ho Lin, Jer-Tsong Hsieh, Chih-Hsin Tang, and Chih-Ho Lai. 2019. "Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways" Cancers 11, no. 1: 34. https://doi.org/10.3390/cancers11010034

Chen, Y.-A., Tzeng, D. T. W., Huang, Y.-P., Lin, C.-J., Lo, U.-G., Wu, C.-L., Lin, H., Hsieh, J.-T., Tang, C.-H., & Lai, C.-H. (2019). Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways. Cancers, 11(1), 34. https://doi.org/10.3390/cancers11010034